BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

938 related articles for article (PubMed ID: 17995521)

  • 1. Pathophysiology of minimal change nephrotic syndrome and focal segmental glomerulosclerosis.
    Cho MH; Hong EH; Lee TH; Ko CW
    Nephrology (Carlton); 2007 Dec; 12 Suppl 3():S11-4. PubMed ID: 17995521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathological diagnosis and outcome of paediatric nephrotic syndrome.
    Ejaz I; Khan HI; Javaid BK; Rasool G; Bhatti MT
    J Coll Physicians Surg Pak; 2004 Apr; 14(4):229-33. PubMed ID: 15228828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell subsets in glomerulonephritis.
    Lin CY; Yang YM; Fu YK
    Int J Pediatr Nephrol; 1986; 7(2):63-8. PubMed ID: 3487514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Class II human leukocyte antigens in minimal change nephrotic syndrome and focal segmental glomerulosclerosis--preliminary study].
    Krasowska-Kwiecień A; Sancewicz-Pach K; Pogan A
    Pol Merkur Lekarski; 2001 Apr; 10(58):256-8. PubMed ID: 11434170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nephrotic syndrom with focal and segmental glomerulosclerosis in Dakar: epidemiological and clinicopathological characteristics (about 134 cases)].
    Niang A; Dial C; Ka EF; Lèye A; Pouye A; Ka MM; Mbengue M; Droz D; Diouf B
    Dakar Med; 2008; 53(1):45-51. PubMed ID: 19102117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glomerular anionic sites in minimal change nephrotic syndrome and focal segmental glomerulosclerosis.
    Kitano Y; Yoshikawa N; Nakamura H
    Clin Nephrol; 1993 Oct; 40(4):199-204. PubMed ID: 8261675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical significance of IgM deposition in the mesangium and mesangial hypercellularity in adult minimal change nephrotic syndrome].
    Maruyama M; Toyoda M; Umezono T; Miyauchi M; Yamamoto N; Kimura M; Honma M; Nishina M; Endoh M; Sakai H; Suzuki D
    Nihon Jinzo Gakkai Shi; 2006; 48(1):14-21. PubMed ID: 16480062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term ciclosporine A treatment in adults with minimal change nephrotic syndrome or focal segmental glomerulosclerosis.
    Ittel TH; Clasen W; Fuhs M; Kindler J; Mihatsch MJ; Sieberth HG
    Clin Nephrol; 1995 Sep; 44(3):156-62. PubMed ID: 8556831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glomerular volume and renal function in children with different types of the nephrotic syndrome.
    Nyberg E; Bohman SO; Berg U
    Pediatr Nephrol; 1994 Jun; 8(3):285-9. PubMed ID: 7917852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nephrotic syndrome associated with diffuse mesangial hypercellularity: is it a heterogeneous disease entity?
    Joh K; Matsuyama N; Kanetsuna Y; Usui N; Hattori M; Yumura W; Aizawa S
    Am J Nephrol; 1998; 18(3):214-20. PubMed ID: 9627037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab in minimal change nephropathy and focal segmental glomerulosclerosis: report of four cases and review of the literature.
    Peters HP; van de Kar NC; Wetzels JF
    Neth J Med; 2008 Nov; 66(10):408-15. PubMed ID: 19011266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance and long-term evolution of minimal change histopathologic variants and of IGM nephropathy among Egyptians.
    Donia AF; Sobh MA; Moustafa FE; Bakr MA; Foda MA
    J Nephrol; 2000; 13(4):275-81. PubMed ID: 10946807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Minimal change nephrotic syndrome : new insights into disease pathogenesis].
    Audard V; Lang P; Sahali D
    Med Sci (Paris); 2008 Oct; 24(10):853-8. PubMed ID: 18950582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A quantitative analysis of the glomeruli in focal segmental glomerulosclerosis.
    Suzuki J; Yoshikawa N; Nakamura H
    Pediatr Nephrol; 1994 Aug; 8(4):416-9. PubMed ID: 7947029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Permeability factors in focal segmental glomerulosclerosis.
    Savin VJ; McCarthy ET; Sharma M
    Semin Nephrol; 2003 Mar; 23(2):147-60. PubMed ID: 12704575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of glomerular hypertrophy in focal segmental glomerulosclerosis.
    Lee HS; Lim SD
    Clin Nephrol; 1995 Dec; 44(6):349-55. PubMed ID: 8719545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glomerulopathy with mesangial IgM deposits: long-term follow up of 64 children.
    Zeis PM; Kavazarakis E; Nakopoulou L; Moustaki M; Messaritaki A; Zeis MP; Nicolaidou P
    Pediatr Int; 2001 Jun; 43(3):287-92. PubMed ID: 11380926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonlupus nephritides in patients with systemic lupus erythematosus: a comprehensive clinicopathologic study and review of the literature.
    Baranowska-Daca E; Choi YJ; Barrios R; Nassar G; Suki WN; Truong LD
    Hum Pathol; 2001 Oct; 32(10):1125-35. PubMed ID: 11679948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversible glomerular hypertrophy in adult patients with primary focal segmental glomerulosclerosis.
    Nishimoto K; Shiiki H; Nishino T; Uyama H; Iwano M; Dohi K
    J Am Soc Nephrol; 1997 Nov; 8(11):1668-78. PubMed ID: 9355069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis.
    Dumoulin A; Hill GS; Montseny JJ; Meyrier A
    Am J Kidney Dis; 2003 Jan; 41(1):38-48. PubMed ID: 12500220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.